Utilizing Tumor and Plasma Liquid Biopsy in Treatment Decision Making for an Estrogen Receptor-Positive Advanced Breast Cancer PatientBing Xu, Brian Leyland‐Jones, Amy Krie et al.|Cureus|2017Cited by 15
Down’s Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical RelationshipNandini Dey, Brian Leyland‐Jones, Rachel Elsey et al.|International Journal of Molecular Sciences|2017Cited by 9
Case report: 16-yr life history and genomic evolution of an ER<sup>+</sup> HER2<sup>−</sup> breast cancerBing Xu, Tobias Meißner, Anu Amallraja et al.|Molecular Case Studies|2020Cited by 3
Value of sequencing-guided treatment for patients with advanced malignancies.Casey Williams, Brian Leyland‐Jones, Robert B. Goldberg et al.|Journal of Clinical Oncology|2016Cited by 0
Abstract P4-05-20: Case report - 16 year life history and genomic evolution of an ER+ HER2- breast cancerBing Xu, Tobias Meißner, Anu Amallraja et al.|Cancer Research|2020Cited by 0